PATRICIA RIVET MURRAY, Judge.
This is a medical malpractice suit. The plaintiffs, Carrie Ferrara and her two adult children,
Since the only issue presented on this appeal is prescription, the pertinent factual and procedural events are set forth in the following time line:
On appeal, Ms. Ferrara assigns as error the trial court's ruling sustaining the prescription exception. The prescriptive period for medical malpractice is set forth in La R.S. 9:5628(A), which provides:
This statute "not only corresponds with the basic one year prescriptive period for delictual actions provided in La. Civil Code art. 3492, [but also] it embodies the discovery rule delineated as the fourth category of contra non valentem." Campo v. Correa, 01-2707, p. 9 (La.6/21/02), 828 So.2d 502, 509. Both the one-year and three-year periods set forth in La. R.S. 9:5628 are prescriptive periods, "with the qualification that the contra non valentem type exception to prescription embodied in the discovery rule is expressly made inapplicable after three years from the act, omission, or neglect." Zoulek v. PIP America, 08-0550, p. 3 (La.App. 4 Cir. 12/10/08), 2 So.3d 511, 514 (quoting Borel v. Young, 07-0419, p. 29 (La.7/01/08)(on reh'g), 989 So.2d 42, 69).
Another pertinent provision is La. R.S. 40:1299.47(A)(2)(a) of the Medical Malpractice Act ("MMA"), which provides that when a medical review panel is timely confected, "[t]he filing of the request for a review of a claim shall suspend the time within which suit must be instituted, ... until ninety days following notification ... to the claimant or his attorney of the issuance of the opinion by the medical review panel." Thus, the filing of a medical malpractice claim with a medical review panel triggers the suspension of prescription specially provided by the MMA, rather than the interruption of the liberative prescriptive period generally provided in the Civil Code. LeBreton v. Rabito, 97-2221, p. 9 (La.7/8/98), 714 So.2d 1226, 1230. The filing of a request for review of a claim suspends the running of prescription against all joint and solidary obligors, and all joint tortfeasors, including but not limited to health care providers, both qualified and not qualified, to the same extent that prescription is suspended against the party or parties that are the subject of the request for review. See Edwards v. Alexander, 42,000 (La.App. 2 Cir. 6/6/07), 960 So.2d 336.
Citing the special prescription and suspension of prescription provisions in the MMA, the Louisiana Supreme Court recently held that the relation back doctrine under La. C.C.P. art. 1153 may not be applied to malpractice actions. Warren v. Louisiana Med. Mut. Ins. Co., 07-0492 (La.6/26/09), 21 So.3d 186(on reh'g), 21 So.3d 186, 202.
Warren, 07-0492 at p. 9, 21 So.3d at 207-08.
A defendant may raise a peremptory exception of prescription at any time. When such an exception is pled before trial, the exception is tried and disposed of in advance of or on the trial of the case. La. C.C.P. art. 929. In the trial of the peremptory exception pleaded at or before the trial of the case, "evidence may be introduced to support or controvert any of the objections pleaded, when the grounds thereof do not appear from the petition." La. C.C.P. art. 931. The trial court is not bound to accept as true the allegations of plaintiffs petition in its trial of the peremptory exception. When evidence is introduced and evaluated at the trial of a peremptory exception, an appellate court must review the entire record to determine whether the trial court manifestly erred with its factual conclusions. "Although the party pleading prescription ordinarily has the burden of proof, the burden is shifted to the plaintiff when the petition on its face reveals that prescription has run." Jambon v. State Farm Fire and Cas. Co., 07-925, p. 4 (La.App. 5 Cir. 3/11/08), 982 So.2d 131, 133; see also Carter v. Haygood, 04-0646, p. 9 (La.1/19/05), 892 So.2d 1261, 1267. Furthermore, if the plaintiff's basis for claiming interruption of prescription is solidary liability between two or more parties, the plaintiff bears the burden of proving that solidary relationship. Younger v. Marshall Industries, Inc., 618 So.2d 866, 869 (La.1993).
Although Ms. Ferrara filed a complaint with the Division of Administration within one year of the date of the alleged medical malpractice, her complaint named as defendants only Tulane and Nurse Jane Doe. The amended complaint naming Ms. Waddell as a defendant was not filed until April 16, 2002, more than one year from the alleged malpractice. The lawsuit naming Ms. Waddell and Starmed as defendants was not filed until August 9, 2002. For the amended complaint and the lawsuit to be considered timely, it is necessary to find that the prescription was suspended. Ms. Ferrara cites three theories to support her contention that prescription was suspended: (i) timely suit against a solidary obligor; (ii) relation back doctrine; and (iii) contra non valentem doctrine. We separately address each theory.
Ms. Ferrara contends that prescription was suspended because she timely
The naming of Nurse Jane Doe in the original complaint did not establish solidary liability because "using fictitious names for an unknown defendant is insufficient to interrupt prescription; suit must be commenced against at least one solidary obligor." Hodges v. Republic Western Ins. Co., 05-0245, p. 8, n. 9 (La.App. 4 Cir. 12/14/05), 921 So.2d 175, 180 (citing Compeaux v. Plaisance Inspection & Enterprises, Inc., 93 1165, p. 8 (La.App. 1 Cir. 6/24/94), 639 So.2d 434, 439).
Ms. Ferrara next contends that her amended complaint, which she filed on April 16, 2002, related back to the original complaint. As discussed above, the Louisiana Supreme Court in Warren, supra, held that the relation back doctrine cannot be applied in medical malpractice cases. The trial court thus did not err in refusing to apply the relation back doctrine to allow the Ms. Ferrara' amended complaint to relate back to the filing of her original complaint.
Ms. Ferrara's final contention is that prescription was suspended by the contra non valentem doctrine. Particularly, she relies on the fourth category of the contra non valentem doctrine, which applies when some cause of action is not known or reasonably knowable by the plaintiff, even though his ignorance is not induced by the defendant. A prerequisite for the fourth category to apply is that "the plaintiff's ignorance of his cause of action cannot be attributable to his own willfulness or neglect, as a plaintiff is deemed to know what he could have learned by reasonable diligence." Edwards v. Alexander, 42,000, p. 21 (La.App. 2 Cir. 6/6/07), 960 So.2d 336, 348 (citing Renfroe, supra.)
Ms. Ferrara contends that it was impossible for her to know the true identity of the nurse who treated her until Tulane, through a petition for discovery, furnished her with this information. Continuing, she points out that when Tulane provided her with that information the one-year prescriptive period had elapsed, but the three-year period of La. R.S. 9:5628 had not elapsed. Thus, she contends that she timely filed the amended panel claim within the three year period against Ms. Waddell once she discovered her identity.
Ms. Waddell and Starmed counter that Ms. Ferrara's reliance on the fourth category of contra non valentum is misplaced. In support, they cite Edwards, supra, in which the appellate court affirmed the trial court's decision sustaining the defendant-doctor's exception of prescription. Finding the plaintiff had constructive knowledge of the defendant's involvement in the patient's care, the court reasoned that "[i]f mention of Dr. Alexander's name on numerous documents in the ER record did not excite plaintiff's curiosity about the involvement of Dr. Alexander in her son's
This case is distinguishable from Edwards, supra. In that case, the defendant-doctor's (Dr. Alexander's) name appeared in type-written form in multiple places in the patient's emergency room records, and there was other evidence establishing the plaintiff's constructive knowledge. In contrast, Ms. Waddell's name does not appear in type-written form in the medical records; rather, her name appears in handwritten form in various places in the nurses notes. The name of Ms. Waddell's employer, Starmed, does not appear in the medical records.
This case is closer to Shortess v. Touro Infirmary, 520 So.2d 389 (La.1988), which the court in Edwards, supra, distinguished. In Shortess, "the medical records did not reveal that the plaintiff's tainted blood came from anywhere other than Touro's blood bank, and the plaintiff had no way of knowing that an outside blood bank was the source of her tainted blood as that could only be discovered by tracing serial numbers through Touro's card files." Edwards, 42,000 at p. 24, 960 So.2d at 349. The appellate court in Shortess found that the defendant-blood supplier's identity was readily discernable from the hospital's records and thus sustained the exception of prescription. Reversing, the Louisiana Supreme Court characterized the appellate court's statement regarding the plaintiff's ability to discern the blood supplier's identity from the hospital's record as "misleading," and the Supreme Court explained that:
Shortess, 520 So.2d at 392 (quoting Walter v. Caffall, 192 La. 447, 188 So. 137 at 143 (1939)).
In this case, Ms. Waddell was working at Tulane as an employee of Starmed, a third party nursing agency, when the malpractice occurred. Although in hindsight Ms. Waddell's name in handwritten form can be discerned from the nurses' notes located in the Tulane medical records, Ms. Ferrara could not have reasonably identified the identity of Ms. Waddell or Starmed until Tulane responded to the discovery request and furnished their identity. Accordingly, we find manifest error and thus reverse the trial court's ruling sustaining the exception of prescription filed by Ms. Waddell and Starmed.
For the foregoing reasons, the judgment of the trial court is reversed.